Treating malignant glioma in Chinese patients: update on temozolomide
Liang Chang,1 Jun Su,1 Xiuzhi Jia,2,3 Huan Ren2,3 1Department of Neurosurgery, The Tumor Hospital of Harbin Medical University, 2Department of Immunology, Harbin Medical University, 3Key Lab Infection and Immunity, Heilongjiang Province, Harbin, People's Republic of China Abstract: Maligna...
Main Authors: | Chang L, Su J, Jia X, Ren H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/treating-malignant-glioma-in-chinese-patients-update-on-temozolomide-a15778 |
Similar Items
-
Temozolomide in malignant glioma
by: Gregor Dresemann
Published: (2010-07-01) -
The strategy for enhancing temozolomide against malignant glioma
by: Mitsutoshi eNakada, et al.
Published: (2012-08-01) -
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
by: Sadhak Sengupta, et al.
Published: (2012-01-01) -
Study for the Adjuvant Therapeutic Effect of Resveratrol and Temozolomide in Malignant Glioma Cells
by: Chien-Ju Lin, et al.
Published: (2012) -
The study of using biodegradable polyanhydride carring temozolomide to inhibit malignant glioma
by: Ssu-Yin Yen, et al.
Published: (2011)